Not a Part of Normal Aging
Even though it’s a serious condition that typically leads to death after the onset of serious symptoms (such as angina and syncope), aortic stenosis (AS) is under-diagnosed—and even more scary—under-treated.
In response to President Obama’s March 9th Executive Order lifting the Bush Administration’s restrictions on stem cell research, the National Institutes of Health (NIH) has issued draft guidelines on the federal funding of this research. The public comment period for the draft is open through May 26th so there’s still time to have your voice heard!
Major Step for Embryonic Stem Cell Research
Reaching a major milestone for embryonic stem cell research (ESCR), the Food and Drug Administration has approved the first human clinical trial for a treatment based on embryonic stem cells. The trial—to be conducted by biotechnology company Geron Corp.—will focus on the safety of a treatment for spinal cord injury. The trial will start with up to 10 paralyzed patients who can be treated within 14 days of their injury. If it’s found safe, the company will expand the trial and shift its focus to effectiveness.
While most people in a recent survey said they would encourage a loved one to seek early diagnosis if they suspected Alzheimer’s disease, when faced with the reality, only a small number sought out early diagnosis.
Voters for the American Express Members Project recently chose the Alzheimer’s Disease: Early Detection Matters campaign as the project they would most like to see funded. Close to 90,000 card members cast a vote—choosing from more than 1,000 potential projects. In the end, the winner was a campaign that will educate people about the importance of early diagnosis of Alzheimer’s—receiving $1.5 million in funding.
Data on Chronic Disease Helps Inform the Debate
While Senators Obama and McCain agree on few things when it comes to overhauling the American health care system, both have acknowledged the importance of a plan that addresses chronic disease—the primary driver of health care costs.




